Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Altimmune, Inc.
ClinicalTrials.gov Identifier:
NCT00755703
First received: September 17, 2008
Last updated: December 31, 2015
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)